Two muffin and three snack bar concepts were designed with or without 30 g of milled brown flaxseed (providing 6 g of ALA) and assigned to taste judges.
A study on flaxseed fortification in the journal Food Research International brings new optimism to fortifying foods for heart health.
Flaxseed contains omega-3 alpha-linolenic acid (ALA), antioxidants, and lignans-all of which have received attention for potential to support the cardiovascular system. But flax can become rancid and effect flavor and aroma if fortified in food products.
Researchers at the University of Manitoba sought to better understand flax fortification in two practical food products: muffins and snack bars. Two muffin and three snack bar concepts were designed with or without 30 g of milled brown flaxseed (providing 6 g of ALA) and assigned to 10 and 11 trained judges, respectively.
In orange cranberry and apple spice muffins, flaxseed imparted increased grain aroma and flavor, and increased bitterness. Overall sweetness and vanilla aromas and flavors were also reduced with flax inclusion.
In orange cranberry, gingerbread raisin, and cappuccino chocolate chip snack bars, no differences were detected in grain aroma or flavor. Spice aroma in the gingerbread raising snack bar was actually increased with flax.
The baking process for muffins and snack bars did not appear to affect the available ALA in the final product, but more research is warranted.
The results of these sensory tests support the need for further exploration of flaxseed fortification. Low levels of flaxseed fortification, with the addition of flavors and antioxidants (for increased shelf life), may provide a novel method for addressing nutrition needs of the general public across a wide range of foods.
Future research on flaxseed fortification should focus on sensory attribute intensities, consumer acceptability, and changes in ALA content from the baking process.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.